Clinical Trials
18 trialsNCT06735560 2026-05-13
ELEGANCE
Nantes University Hospital
Phase NA Recruiting
NCT07479264 2026-03-18
A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT07224737 2026-03-13
EXOMIC
City of Hope Medical Center
Completed
NCT07225452 2026-03-13
LUMIC
City of Hope Medical Center
Completed
NCT06859684 2026-03-09
HAIC-quad
West China Hospital
Phase 2 Recruiting
NCT06739252 2026-01-28
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
Peking University
Phase 2 Terminated
NCT07353827 2026-01-20
FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07337850 2026-01-13
FAPi-2
Tata Memorial Centre
Recruiting
NCT07304388 2025-12-30
HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC
Sun Yat-sen University
Phase 2 Completed
NCT06925516 2025-11-28
ACADEMY
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT07153783 2025-11-18
Interventional AI-Human Collaboration for Liver Tumor Diagnosis
Shengjing Hospital
Phase NA Completed
NCT07208526 2025-10-06
A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
Shanghai Zhongshan Hospital
Phase NA Not yet recruiting
NCT07176962 2025-09-16
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Shanghai Jiao Tong University School of Medicine
Recruiting
NCT07161869 2025-09-09
POELH-III
Erasmus Medical Center
Not yet recruiting
NCT07128290 2025-08-17
PEHRICCA
Federation Francophone de Cancerologie Digestive
Phase 2 Not yet recruiting
NCT07070700 2025-08-12
CASTLE-ZS-02
Fudan University
Phase 2 Recruiting
NCT07043348 2025-07-20
ISTAR-04
Seoul National University Hospital
Terminated
NCT07063888 2025-07-14
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting